Frank E. Thomas - Oct 4, 2022 Form 4 Insider Report for Orchard Therapeutics plc (ORTX)

Role
Title: President & Chief Operating Officer
Signature
/s/ Frank E. Thomas
Stock symbol
ORTX
Transactions as of
Oct 4, 2022
Transactions value $
$0
Form type
4
Date filed
10/6/2022, 06:11 PM
Previous filing
Sep 19, 2022
Next filing
Feb 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORTX Stock Option (Right to Buy) Disposed to Issuer $0 -426K -100% $0.00* 0 Oct 4, 2022 Ordinary Shares 426K $2.44 Direct F1, F2, F3
transaction ORTX Stock Option (Right to Buy) Award $0 +426K $0.00 426K Oct 4, 2022 Ordinary Shares 426K $0.58 Direct F1, F2, F3
transaction ORTX Stock Option (Right to Buy) Disposed to Issuer $0 -184K -100% $0.00* 0 Oct 4, 2022 Ordinary Shares 184K $9.06 Direct F1, F2, F3
transaction ORTX Stock Option (Right to Buy) Award $0 +184K $0.00 184K Oct 4, 2022 Ordinary Shares 184K $0.58 Direct F1, F2, F3
transaction ORTX Stock Option (Right to Buy) Disposed to Issuer $0 -100K -100% $0.00* 0 Oct 4, 2022 Ordinary Shares 100K $12.54 Direct F1, F3, F4
transaction ORTX Stock Option (Right to Buy) Award $0 +100K $0.00 100K Oct 4, 2022 Ordinary Shares 100K $0.58 Direct F1, F3, F4
transaction ORTX Stock Option (Right to Buy) Disposed to Issuer $0 -200K -100% $0.00* 0 Oct 4, 2022 Ordinary Shares 200K $13.58 Direct F1, F3, F5
transaction ORTX Stock Option (Right to Buy) Award $0 +200K $0.00 200K Oct 4, 2022 Ordinary Shares 200K $0.58 Direct F1, F3, F5
transaction ORTX Stock Option (Right to Buy) Disposed to Issuer $0 -150K -100% $0.00* 0 Oct 4, 2022 Ordinary Shares 150K $7.05 Direct F1, F3, F6
transaction ORTX Stock Option (Right to Buy) Award $0 +150K $0.00 150K Oct 4, 2022 Ordinary Shares 150K $0.58 Direct F1, F3, F6
transaction ORTX Stock Option (Right to Buy) Disposed to Issuer $0 -310K -100% $0.00* 0 Oct 4, 2022 Ordinary Shares 310K $5.98 Direct F1, F3, F7
transaction ORTX Stock Option (Right to Buy) Award $0 +310K $0.00 310K Oct 4, 2022 Ordinary Shares 310K $0.58 Direct F1, F3, F7
transaction ORTX Stock Option (Right to Buy) Disposed to Issuer $0 -27.7K -100% $0.00* 0 Oct 4, 2022 Ordinary Shares 27.7K $5.98 Direct F1, F2, F3
transaction ORTX Stock Option (Right to Buy) Award $0 +27.7K $0.00 27.7K Oct 4, 2022 Ordinary Shares 27.7K $0.58 Direct F1, F2, F3
transaction ORTX Stock Option (Right to Buy) Award $0 +458K $0.00 458K Oct 4, 2022 Ordinary Shares 458K $0.58 Direct F3, F8
transaction ORTX Stock Option (Right to Buy) Award $0 +75K $0.00 75K Oct 4, 2022 Ordinary Shares 75K $0.58 Direct F3, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 4, 2022, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
F2 The shares subject to this option are fully vested and exercisable as of the date hereof.
F3 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F4 The shares subject to this option vest in equal monthly installments over the four years after January 16, 2019.
F5 The shares subject to this option vest in equal monthly installments over the four years after January 2, 2020.
F6 The shares subject to this option vest in equal monthly installments over the four years after April 1, 2020.
F7 The shares subject to this option vest in equal monthly installments over the four years after February 1, 2021.
F8 The shares subject to this option vest in equal monthly installments over the three years after October 4, 2022.
F9 The shares subject to this option vest in equal monthly installments over the two years after July 1, 2024.

Remarks:

Title: President & Chief Operating Officer